Jounce Therapeutics, Inc. develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial. It is also developing JTX-8064, an antibody that binds to leukocyte immunoglobulin like receptor B2.
Market Cap | 251.654 Million | Shares Outstanding | 51.674 Million | Avg 30-day Volume | 260.471 Thousand |
P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -0.59 |
Price to Revenue | 0.0 | Debt to Equity | 0.0 | EBITDA | -254.901 Million |
Price to Book Value | 0.9927 | Operating Margin | 0.0 | Enterprise Value | -5.671 Million |
Current Ratio | 6.784 | EPS Growth | -7.433 | Quick Ratio | 6.405 |
1 Yr BETA | 1.3046 | 52-week High/Low | 9.81 / 2.76 | Profit Margin | 0.0 |
Operating Cash Flow Growth | -97.696 | Altman Z-Score | -2.9672 | Free Cash Flow to Firm | -55.281 Million |
Earnings Report | 2022-11-03 |
Please sign in first
none
none
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
COLE HUGH M CHIEF OPERATING OFFICER |
|
166,716 | 2022-08-01 | 4 |
|
20,000 | 2022-06-24 | 1 | |
|
20,000 | 2022-06-24 | 1 | |
|
20,000 | 2022-06-24 | 1 | |
|
20,000 | 2022-06-24 | 1 | |
|
20,000 | 2022-06-24 | 1 | |
|
20,000 | 2022-06-24 | 1 | |
|
20,000 | 2022-06-24 | 3 | |
|
20,000 | 2022-06-24 | 1 | |
MURRAY RICHARD /CA/ CEO AND PRESIDENT |
|
448,077 | 2022-02-01 | 2 |
DRAPKIN KIMBERLEE C CFO AND TREASURER |
|
135,114 | 2022-02-01 | 2 |
TREHU ELIZABETH CHIEF MEDICAL OFFICER |
|
167,702 | 2022-02-01 | 2 |
|
4,698,661 | 2021-11-12 | 2 | |
|
50,468 | 2021-11-12 | 2 | |
|
3,332,638 | 2021-09-15 | 2 | |
|
5,539,727 | 2020-10-16 | 0 | |
|
0 | 2020-06-26 | 0 | |
|
3,456,463 | 2017-02-01 | 0 | |
THIRD ROCK VENTURES GP II, L.P. |
|
3,048,780 | 2017-02-01 | 0 |
|
No longer subject to file | 2017-02-01 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2022-08-03 20:29:55 -0400 | 2022-08-01 | A | 20,000 | a | 126,716 | direct | 14.9171 | 28.453 | 35.9116 | 5 | 0.0 | 1 | ||||
2022-08-03 20:29:55 -0400 | 2022-08-01 | A | 40,000 | a | 40,000 | direct | ||||||||||
2022-06-28 21:07:14 -0400 | 2022-06-24 | A | 20,000 | a | 20,000 | direct | ||||||||||
2022-06-28 21:02:17 -0400 | 2022-06-24 | A | 20,000 | a | 20,000 | direct | ||||||||||
2022-06-28 21:03:20 -0400 | 2022-06-24 | A | 20,000 | a | 20,000 | direct | ||||||||||
2022-06-28 21:00:34 -0400 | 2022-06-24 | A | 20,000 | a | 20,000 | direct | ||||||||||
2022-06-28 21:05:21 -0400 | 2022-06-24 | A | 20,000 | a | 20,000 | direct | ||||||||||
2022-06-28 21:06:15 -0400 | 2022-06-24 | A | 20,000 | a | 20,000 | direct | ||||||||||
2022-06-28 21:08:09 -0400 | 2022-06-24 | A | 20,000 | a | 20,000 | direct | ||||||||||
2022-06-28 21:08:53 -0400 | 2022-06-24 | A | 20,000 | a | 20,000 | direct |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
JOUNCE THERAPEUTICS INC JNCE | 2022-08-16 22:15:05 UTC | 1.081 | 1.239 | 1100000 |
JOUNCE THERAPEUTICS INC JNCE | 2022-08-16 21:45:03 UTC | 1.081 | 1.239 | 1100000 |
JOUNCE THERAPEUTICS INC JNCE | 2022-08-16 21:15:03 UTC | 1.081 | 1.239 | 1100000 |
JOUNCE THERAPEUTICS INC JNCE | 2022-08-16 20:45:05 UTC | 1.081 | 1.239 | 1100000 |
JOUNCE THERAPEUTICS INC JNCE | 2022-08-16 20:15:04 UTC | 1.081 | 1.239 | 1100000 |
JOUNCE THERAPEUTICS INC JNCE | 2022-08-16 19:45:04 UTC | 1.081 | 1.239 | 1100000 |
JOUNCE THERAPEUTICS INC JNCE | 2022-08-16 19:15:05 UTC | 1.081 | 1.239 | 1100000 |
JOUNCE THERAPEUTICS INC JNCE | 2022-08-16 18:45:04 UTC | 1.081 | 1.239 | 1100000 |
JOUNCE THERAPEUTICS INC JNCE | 2022-08-16 18:15:05 UTC | 1.081 | 1.239 | 1100000 |
JOUNCE THERAPEUTICS INC JNCE | 2022-08-16 17:45:04 UTC | 1.081 | 1.239 | 1100000 |
JOUNCE THERAPEUTICS INC JNCE | 2022-08-16 17:15:04 UTC | 1.081 | 1.239 | 1100000 |
JOUNCE THERAPEUTICS INC JNCE | 2022-08-16 16:45:04 UTC | 1.081 | 1.239 | 1100000 |
JOUNCE THERAPEUTICS INC JNCE | 2022-08-16 16:15:04 UTC | 1.081 | 1.239 | 1100000 |
JOUNCE THERAPEUTICS INC JNCE | 2022-08-16 15:45:04 UTC | 1.081 | 1.239 | 1100000 |
JOUNCE THERAPEUTICS INC JNCE | 2022-08-16 15:15:03 UTC | 1.081 | 1.239 | 1000000 |
JOUNCE THERAPEUTICS INC JNCE | 2022-08-16 14:45:03 UTC | 1.081 | 1.239 | 1000000 |
JOUNCE THERAPEUTICS INC JNCE | 2022-08-16 14:15:04 UTC | 1.081 | 1.239 | 1000000 |
JOUNCE THERAPEUTICS INC JNCE | 2022-08-16 13:45:05 UTC | 1.081 | 1.239 | 1000000 |
JOUNCE THERAPEUTICS INC JNCE | 2022-08-16 13:15:04 UTC | 1.081 | 1.239 | 1000000 |
JOUNCE THERAPEUTICS INC JNCE | 2022-08-16 12:45:03 UTC | 1.081 | 1.239 | 1000000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|